Nomura Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2M Buy
237,225
+13,290
+6% +$1.04M 0.15% 267
2025
Q4
$17.7M Buy
223,935
+28,417
+15% +$2.46M 0.05% 351
2025
Q3
$17.9M Buy
195,518
+151,805
+347% +$12.4M 0.08% 343
2025
Q2
$2.85M Sell
43,713
-173,463
-80% -$11.3M 0.02% 736
2025
Q1
$14.5M Buy
217,176
+3,297
+2% +$197K 0.08% 370
2024
Q4
$11.8M Buy
213,879
+3,255
+2% +$187K 0.06% 455
2024
Q3
$12.6M Buy
+210,624
New +$12.8M 0.09% 381
2019
Q4
Sell
-405,511
Closed -$29.4M 1095
2019
Q3
$29.4M Buy
405,511
+30,062
+8% +$2.25M 0.24% 150
2019
Q2
$31.1M Buy
375,449
+95,462
+34% +$6.79M 0.29% 130
2019
Q1
$19.5M Buy
279,987
+209,441
+297% +$12.3M 0.18% 186
2018
Q4
$3.17M Sell
70,546
-206,463
-75% -$10.8M 0.03% 604
2018
Q3
$15.6M Sell
277,009
-33,106
-11% -$2.03M 0.11% 272
2018
Q2
$20.7M Buy
310,115
+28,134
+10% +$1.76M 0.15% 230
2018
Q1
$16.4K Sell
281,981
-2,280
-0.8% -$145K 0.07% 294
2017
Q4
$18.3M Buy
284,261
+43,733
+18% +$2.72M 0.13% 306
2017
Q3
$12.6M Buy
240,528
+31,179
+15% +$1.49M 0.12% 330
2017
Q2
$9.74M Buy
209,349
+448
+0.2% +$21.6K 0.08% 379
2017
Q1
$10.4M Buy
208,901
+1,164
+0.6% +$65.4K 0.12% 294
2016
Q4
$12.6M Buy
207,737
+1,346
+0.7% +$82.3K 0.11% 319
2016
Q3
$13.7M Buy
206,391
+25,327
+14% +$1.58M 0.13% 227
2016
Q2
$10.1M Buy
181,064
+178,946
+8,449% +$8.7M 0.16% 285
2016
Q1
$72K Sell
2,118
-164,632
-99% -$5.58M ﹤0.01% 1423
2015
Q4
$7.52M Buy
166,750
+4,237
+3% +$182K 0.09% 303
2015
Q3
$6.48M Buy
162,513
+11,016
+7% +$627K 0.08% 321
2015
Q2
$9.01M Buy
151,497
+2,496
+2% +$149K 0.07% 284
2015
Q1
$9.03M Buy
149,001
+138,589
+1,331% +$8.43M 0.11% 253
2014
Q4
$567K Buy
+10,412
New +$459K 0.01% 1582
2013
Q3
Sell
-9,928
Closed -$59K 2317
2013
Q2
$59K Buy
+9,928
New +$69.5K ﹤0.01% 2057

Other funds holding ANIP